| Financial Year |
March 31 2023 |
| Monetary Funds |
7,983,277,913.46 |
| Held-for-trading Financial Assets |
12,640,000.00 |
| Notes Receivable |
74,604,279.73 |
| Accounts Receivable |
3,302,403,946.08 |
| Advances to Suppliers |
2,469,466,082.93 |
| Other Receivables |
220,612,050.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
9,548,000.00 |
| Inventories |
2,678,192,248.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
982,122,595.95 |
| Other Current Assets |
366,288,082.54 |
| Total Current Assets |
19,047,451,999.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,809,949,467.94 |
| Long-term Equity Investment |
491,693,725.08 |
| Investment Properties |
531,513,423.44 |
| Fixed Assetes |
133,547,006.55 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,031,952.88 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,012,433.36 |
| Deferred Income Tax Assets |
403,400,367.47 |
| Other Non-Current Assets |
49,485,763.46 |
| Sub-Total of Non-Current Assets |
7,700,110,771.82 |
| Total Assets |
26,747,562,770.90 |
| Short-Term Loans |
400,498,055.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,613,356,869.54 |
| Accounts Payable |
6,708,791,094.45 |
| Accounts Received In Advance |
5,392,729.16 |
| Employee Compensation Payable |
14,301,072.34 |
| Taxes Payable |
182,123,240.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
91,623,598.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
101,198,285.11 |
| Other Current Liabilities |
186,367,126.81 |
| Sub-Total of Current Liabilities |
18,000,840,969.01 |
| Long-term Loans |
720,921,295.31 |
| Bonds Payable |
805,124,962.21 |
| Long-Term Accounts Payable |
3,017,883.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
14,898,120.32 |
| Deferred Income Tax Liabilities |
59,291,588.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,740,443,407.81 |
| Total Liabilities |
19,741,284,376.82 |
| Paid-In Capital(Or Share Stock) |
1,281,080,999.00 |
| Capital Surplus |
1,965,113,943.60 |
| Surplus Reserve |
258,299,793.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,186,683,018.45 |
| Minority Stockholder's Interest |
258,902,463.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,747,375,930.30 |
| Owner's Equity（Stockholder's Equity） |
7,006,278,394.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,747,562,770.90 |
